HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Bicycle Therapeutics (NASDAQ:BCYC) with a Buy and maintains $57 price target.
WTW Launches Climate Quantified Technology to Help Quantify the Financial Impact of Climate Change
WTW (NASDAQ:WTW), a leading global advisory, broking and solutions company, today unveiled ground-breaking technology capable of quantifying the financial impact of climate change with an unprecedented level of
